Immune Checkpoint Receptor Could Be Used to Develop MPM Treatment
The immune checkpoint receptor TIM-3 could be a promising path toward treating pleural mesothelioma, a Belgium study suggests. The research, “Prognostic and predictive aspects of the tumor immune...
View ArticleDovitinib Inhibitor Shows Minimal Activity in Treatment of MPM
Dovitinib, an inhibitor of the VEGF and FGF signaling pathways, seems to have only minimal activity in patients with malignant pleural mesothelioma (MPM) who received prior chemotherapy treatment,...
View ArticleImprovement in Photodynamic Therapy for Malignant Pleural Mesothelioma
An improved lighting and tracking technique in photodynamic therapy (PDT) for treating malignant pleural mesothelioma (MPM) was successful in the laboratory using a mock-up of a human hemithorax. The...
View ArticleNutritional CONUT Score Predicts Poor Prognosis in Mesothelioma Patients,...
Good nutrition was found to be a prognostic factor for patients with malignant pleural mesothelioma (MPM). Determining the controlling nutritional status (CONUT) score as a measure of nutrition could...
View ArticleCrizotinib-Afatinib Combination Halves Mesothelioma Growth in Mice, Study Shows
A combination of crizotinib and afatinib does a better job of inhibiting the growth of malignant pleural mesothelioma (MPM) cancer cells than either therapy alone, according to a study. Together, the...
View ArticleHEG1 Protein is a Specific, Sensitive Biomarker for Malignant Mesothelioma,...
Japanese researchers have demonstrated that the modified form of the HEG1 protein is a highly specific marker and a useful diagnostic tool for malignant mesothelioma (MM). The protein is also linked to...
View ArticleBlood Levels May Help Diagnose, Monitor Asbestos-Related Diseases, Chinese...
High levels of a naturally occurring protein, high-mobility group box 1 (HMGB1), are present in the blood of people with asbestos exposure and even higher in two asbestos-related diseases —...
View ArticleElectron Microscopy Still a Valuable Tool for Diagnosing Mesothelioma,...
Despite advances in diagnostic tools available to scientists, electron microscopy (EM) remains important in the diagnosis of many diseases, including malignant pleural mesothelioma (MPM). This is...
View ArticleComplete Surgical Removal of Mesothelioma Tumor Can Prolong Survival, Review...
Complete surgical removal of mesothelioma tissue significantly prolongs survival in those with the cancer, according to researchers who reviewed a number of studies on this treatment approach. The...
View ArticleNew-generation Radiation, Combined with Surgery, Is Effective Against...
A new-generation radiation therapy introduced in 2007 is effective against malignant pleural mesothelioma, a New York study reports. The researchers at the Icahn School of Medicine at Mount Sinai said...
View ArticleImmune Checkpoint Receptor Could Be Used to Develop MPM Treatment
The immune checkpoint receptor TIM-3 could be a promising path toward treating pleural mesothelioma, a Belgium study suggests. The research, “Prognostic and predictive aspects of the tumor immune...
View ArticleDovitinib Inhibitor Shows Minimal Activity in Treatment of MPM
Dovitinib, an inhibitor of the VEGF and FGF signaling pathways, seems to have only minimal activity in patients with malignant pleural mesothelioma (MPM) who received prior chemotherapy treatment,...
View ArticleImprovement in Photodynamic Therapy for Malignant Pleural Mesothelioma
An improved lighting and tracking technique in photodynamic therapy (PDT) for treating malignant pleural mesothelioma (MPM) was successful in the laboratory using a mock-up of a human hemithorax. The...
View ArticleNutritional CONUT Score Predicts Poor Prognosis in Mesothelioma Patients,...
Good nutrition was found to be a prognostic factor for patients with malignant pleural mesothelioma (MPM). Determining the controlling nutritional status (CONUT) score as a measure of nutrition could...
View ArticleCrizotinib-Afatinib Combination Halves Mesothelioma Growth in Mice, Study Shows
A combination of crizotinib and afatinib does a better job of inhibiting the growth of malignant pleural mesothelioma (MPM) cancer cells than either therapy alone, according to a study. Together, the...
View ArticleHEG1 Protein is a Specific, Sensitive Biomarker for Malignant Mesothelioma,...
Japanese researchers have demonstrated that the modified form of the HEG1 protein is a highly specific marker and a useful diagnostic tool for malignant mesothelioma (MM). The protein is also linked to...
View ArticleBlood Levels May Help Diagnose, Monitor Asbestos-Related Diseases, Chinese...
High levels of a naturally occurring protein, high-mobility group box 1 (HMGB1), are present in the blood of people with asbestos exposure and even higher in two asbestos-related diseases —...
View ArticleElectron Microscopy Still a Valuable Tool for Diagnosing Mesothelioma,...
Despite advances in diagnostic tools available to scientists, electron microscopy (EM) remains important in the diagnosis of many diseases, including malignant pleural mesothelioma (MPM). This is...
View ArticleComplete Surgical Removal of Mesothelioma Tumor Can Prolong Survival, Review...
Complete surgical removal of mesothelioma tissue significantly prolongs survival in those with the cancer, according to researchers who reviewed a number of studies on this treatment approach. The...
View ArticleNew-generation Radiation, Combined with Surgery, Is Effective Against...
A new-generation radiation therapy introduced in 2007 is effective against malignant pleural mesothelioma, a New York study reports. The researchers at the Icahn School of Medicine at Mount Sinai said...
View Article